0001367644-23-000179.txt : 20231005
0001367644-23-000179.hdr.sgml : 20231005
20231005191023
ACCESSION NUMBER: 0001367644-23-000179
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231003
FILED AS OF DATE: 20231005
DATE AS OF CHANGE: 20231005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fowler Neal Franklin
CENTRAL INDEX KEY: 0001493692
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 231312399
MAIL ADDRESS:
STREET 1: C/O EMERGENT BIOSOLUTIONS INC.
STREET 2: 400 PROFESSIONAL DR. STE. 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
wk-form4_1696547413.xml
FORM 4
X0508
4
2023-10-03
0
0001367644
Emergent BioSolutions Inc.
EBS
0001493692
Fowler Neal Franklin
400 PROFESSIONAL DRIVE, SUITE 400
GAITHERSBURG
MD
20879
1
0
0
0
0
Common Stock
2023-10-03
4
A
0
118670
0
A
118670
D
Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. These restricted stock units will vest in three equal installments over a three-year period assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
/s/ Jennifer Lynn Fox, Attorney-in-fact
2023-10-05